In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...